Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results
Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Background: Hyposmia is frequently reported as an initial symptom in coronavirus disease 2019 (COVID-19). Objective: As hyposmia accompanies cognitive impairment in several neurological disorders, we aimed to study whether hyposmia represents a clinical biomarker for both neurological involvement and cognitive impairment in mild COVID-19. We aimed...
Alternative Titles
Full title
Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_karger_primary_515575
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_515575
Other Identifiers
ISSN
1420-8008
E-ISSN
1421-9824
DOI
10.1159/000515575
